WO2002007743A3 - Piper methysticum pflanzenextrakt - Google Patents

Piper methysticum pflanzenextrakt Download PDF

Info

Publication number
WO2002007743A3
WO2002007743A3 PCT/CH2001/000462 CH0100462W WO0207743A3 WO 2002007743 A3 WO2002007743 A3 WO 2002007743A3 CH 0100462 W CH0100462 W CH 0100462W WO 0207743 A3 WO0207743 A3 WO 0207743A3
Authority
WO
WIPO (PCT)
Prior art keywords
extract
piper methysticum
forster
plant extract
taken
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CH2001/000462
Other languages
English (en)
French (fr)
Other versions
WO2002007743A2 (de
Inventor
Bernd Bueter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VITAPLANT AG
Original Assignee
VITAPLANT AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VITAPLANT AG filed Critical VITAPLANT AG
Priority to AU2001278341A priority Critical patent/AU2001278341A1/en
Priority to EP01956248A priority patent/EP1318825A2/de
Publication of WO2002007743A2 publication Critical patent/WO2002007743A2/de
Anticipated expiration legal-status Critical
Publication of WO2002007743A3 publication Critical patent/WO2002007743A3/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Extrakt von Piper methysticum G. Forster, der aus oberirdisch wachsenden Teilen dieser Pflanze, insbesondere den Blättern, gewonnen wird, bietet Vorteile in Bezug auf Wirkung sowie Gewinnung und unterschneidet sich ausweislich HPLC-Analyse deutlich von den bekannten Extrakten aus Wurzelmaterial. Ein solcher Extrakt ist durch Extraktion von oberirdisch wachsendem Pflanzenmaterial von Piper methysticum G. Forster, vorzugsweise dem Blattmaterial, erhältlich und eignet sich für Arzneimittel mit anxiolytischerm antikonvulsiver, muskelrelaxierender, narkosepotenzierender, schmerzstillender, schlafinduzierender, entzündungshemmender und/oder neuroprotektiver Wirkung.
PCT/CH2001/000462 2000-07-26 2001-07-26 Piper methysticum pflanzenextrakt Ceased WO2002007743A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001278341A AU2001278341A1 (en) 2000-07-26 2001-07-26 Piper methysticum plant extract
EP01956248A EP1318825A2 (de) 2000-07-26 2001-07-26 Piper methysticum pflanzenextrakt

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH14762000 2000-07-26
CH1476/00 2000-07-26

Publications (2)

Publication Number Publication Date
WO2002007743A2 WO2002007743A2 (de) 2002-01-31
WO2002007743A3 true WO2002007743A3 (de) 2003-04-03

Family

ID=4565510

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CH2001/000462 Ceased WO2002007743A2 (de) 2000-07-26 2001-07-26 Piper methysticum pflanzenextrakt

Country Status (4)

Country Link
US (1) US20030180395A1 (de)
EP (1) EP1318825A2 (de)
AU (1) AU2001278341A1 (de)
WO (1) WO2002007743A2 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534455B2 (en) * 2000-03-09 2009-05-19 Yale University Herbal composition PHY906 and its use in chemotherapy
US7105185B2 (en) * 2001-10-03 2006-09-12 Herbalscience, Llc Kavalactone profile
US20050053678A1 (en) * 2001-10-03 2005-03-10 Gow Robert T. Methods and compositions for betel nut chewing gum
US7887860B2 (en) * 2001-12-28 2011-02-15 Inter American University Of Puerto Rico Anti-bacterial plant compositions
US20050037025A1 (en) * 2002-10-03 2005-02-17 Gow Robert T. Methods and compositions comprising kava and mate' or theobromine
US20050042314A1 (en) * 2003-08-22 2005-02-24 National Yang-Ming University Extracts of Polygonum multiflorum Thunb., and preparation process and uses of the same
US20050169856A1 (en) * 2004-01-29 2005-08-04 L'oreal Coloring composition, process of making, uses thereof
US20070020305A1 (en) * 2004-02-11 2007-01-25 Board Of Regents For Oklahoma State University Attractant for monitoring or controlling female stored product moths
US7435430B2 (en) * 2004-05-28 2008-10-14 Mmi Corporation Natural sedative composition, process for obtaining the same and pharmaceutical formulations thereof
KR100702567B1 (ko) * 2004-06-09 2007-04-02 퓨리메드 주식회사 심근경색 발작 후 회복을 위한 지각 추출물 및 이를 함유하는 약학적 조성물과 건강 식품
US20060088609A1 (en) * 2004-10-26 2006-04-27 Miri Seiberg Compositions containing Cotinus coggygria extract and use thereof on mucosal tissues
US20060088615A1 (en) * 2004-10-26 2006-04-27 Miri Seiberg Compositions containing Malva sylvestris extract and use thereof on skin and mucosal tissues
US20060165817A1 (en) * 2004-10-26 2006-07-27 Miri Seiberg Compositions containing Cotinus coggygria extract and use thereof in treating wounds
US7754248B2 (en) * 2004-10-26 2010-07-13 Johnson & Johnson Consumer Companies, Inc. Ingestible compositions containing extracts
US20060088608A1 (en) * 2004-10-26 2006-04-27 Miri Seiberg Compositions containing cotinus coggygria extract and use thereof on skin and mucosal tissues
US20060134234A1 (en) * 2004-12-17 2006-06-22 L'oreal Cosmetic composition
WO2008032331A1 (en) * 2006-09-12 2008-03-20 Himalaya Global Holdings Ltd. Herbal composition for the prevention of wrinkles and skin disorders, methods of preparing the same and uses thereof
AU2008256521B2 (en) * 2007-05-29 2014-09-04 Dicot Ab Novel compounds and pharmaceutical preparations from Neobeguea spec
GB0710536D0 (en) * 2007-06-01 2007-07-11 Veritron Ltd Plant extract and its therapeutic use
CA2698740A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of rheum palmatum l of the polygonaceae family and uses thereof
US20090092689A1 (en) * 2007-10-05 2009-04-09 Sylmark Holdings Limited Composition and method for supporting female sexual health
US20110027399A1 (en) * 2008-03-31 2011-02-03 Hiroshima University Antiviral Agent and Antiviral Composition
KR20100135887A (ko) * 2008-05-23 2010-12-27 유겐가이샤 니시하라 Ｂｃｌ-2 단백질 발현제, 아포토시스 억제제 및 표피 세포의 자외선 ｄｎａ 장해 방지제
US9089526B2 (en) * 2009-06-01 2015-07-28 Universidad De Chile Pharmaceutical product and analysis model for hormone replacement therapy for women and prevention of some cancers and uterine myomas
EP2440212A4 (de) 2009-06-12 2013-03-20 Generex Pharm Inc Zusammensetzungen und verfahren zur prävention und behandlung von koronaren herzerkrankungen
JP5364206B2 (ja) * 2009-07-14 2013-12-11 スンチョニャン ユニバーシティ インダストリー アカデミー コーポレイション ファウンデーション 高麗人参アブソリュート精油を含むにきび治療用石鹸組成物
WO2011035314A2 (en) * 2009-09-21 2011-03-24 Total Nutraceutical Solutions, Inc. Vitamin d2 enriched mushrooms and fungi for treatment of oxidative stress, alzheimer's disease and associated disease states
WO2011051742A1 (en) 2009-10-28 2011-05-05 Modutech S.A. Preparation comprising amino acids and plants and its activity in the alcohol detoxification
KR101784940B1 (ko) * 2010-08-31 2017-10-12 (주)아모레퍼시픽 피부 탄력 개선용 화장료 조성물
US9867772B2 (en) 2010-08-31 2018-01-16 Amorepacific Corporation Cosmetic composition for improving skin elasticity
US9278104B2 (en) * 2010-10-26 2016-03-08 In Ingredients, Inc. Methods and materials for reducing multiple risk factors associated with the metabolic syndrome
WO2013090715A1 (en) 2011-12-15 2013-06-20 Metaproteomics, Llc Phytonutrient compositions and methods to protect against radical mediated cellular and dna damage
US20130337092A1 (en) * 2011-12-15 2013-12-19 Metaproteomics, Llc Phytonutrient compositions and methods of use
IN2014DN05615A (de) 2012-01-25 2015-04-03 Dicotyledon Ab
BR112014019167A8 (pt) * 2012-02-29 2017-07-11 Avon Prod Inc Uso de moduladores da carnitina palmitoil transferase-1 (cpt-1) para tratar condição da pele definida por lipídios em excesso ou lipídios subcutâneos insuficientes e para reduzir a recorrência de celulite, bem como composições cosméticas compreendendo os referidos moduladores e método para identificá-los
US20140193529A1 (en) * 2013-01-07 2014-07-10 Avon Products, Inc. Modulation of Thymosin Beta-4 in Skin
US9144564B2 (en) * 2013-03-21 2015-09-29 Julius Zecchino Delivery system having stabilized ascorbic acid and other actives
US9603882B2 (en) * 2013-08-13 2017-03-28 Industrial Technology Research Institute Method for modulating Th17 cells and method for treating a disease related to modulation of Th17 cells
IT201700081175A1 (it) * 2017-07-18 2019-01-18 Nobil Bio Ricerche Srl Dispositivi implantari rivestiti
FR3074998B1 (fr) * 2017-12-18 2020-03-27 Laboratoires Goemar Procede pour identifier et isoler des composes bioactifs a partir d'extraits d'algues
WO2020102559A1 (en) * 2018-11-14 2020-05-22 Westhuizen Pieter Theron Van Der A method of making a flavonoid solution and applications thereof for plant growth promotion, seed coating, pathogen elimination, and herbicide stunting effect removal
US20210228663A1 (en) * 2020-01-24 2021-07-29 Food Technology And Design Llc, Dba Foodpharma Compositions comprising organic mineral chelates, niacinamide, and hemp oil and uses thereof for neuroprotection, cardioprotection, detoxification, immune support, and anti-aging
US20220110852A1 (en) * 2020-10-14 2022-04-14 Chanda Zaveri Pigment Stabilizers
CN115006314B (zh) * 2022-07-11 2023-07-11 科乐美(广州)生物科技有限公司 一种卡瓦胡椒提取物及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004036A1 (de) * 1990-09-12 1992-03-19 Dr. Willmar Schwabe Gmbh & Co. Kawa-kawa-extrakt, verfahren zu seiner herstellung und seine verwendung
EP0987026A1 (de) * 1998-08-21 2000-03-22 Max Zeller Söhne AG Verfahren zur Herstellung eines Kawa-Kawa-Extraktes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004036A1 (de) * 1990-09-12 1992-03-19 Dr. Willmar Schwabe Gmbh & Co. Kawa-kawa-extrakt, verfahren zu seiner herstellung und seine verwendung
EP0987026A1 (de) * 1998-08-21 2000-03-22 Max Zeller Söhne AG Verfahren zur Herstellung eines Kawa-Kawa-Extraktes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; June 2001 (2001-06-01), DINH LONG DOAN ET AL: "Interaction of various Piper methysticum cultivars with CNS receptors in vitro.", XP002224195, Database accession no. PREV200100390980 *
PLANTA MEDICA, vol. 67, no. 4, June 2001 (2001-06-01), pages 306 - 311, ISSN: 0032-0943 *

Also Published As

Publication number Publication date
WO2002007743A2 (de) 2002-01-31
EP1318825A2 (de) 2003-06-18
AU2001278341A1 (en) 2002-02-05
US20030180395A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
WO2002007743A3 (de) Piper methysticum pflanzenextrakt
Qadir et al. Hepatoprotective activity of aqueous methanolic extract of Viola odorata against paracetamol-induced liver injury in mice
Taur et al. Antinociceptive activity of Ricinus communis L. leaves
WO2002047706A3 (en) Selective cox-2 inhibition from plant extracts
DE60206474D1 (de) Prozess zur herstellung eines matrin enthaltenden pflanzenextrakts
Sowemimo et al. Anti-inflammatory activity of Markhamia tomentosa (Benth.) K. Schum. Ex Engl. ethanolic leaf extract
CA2242373A1 (en) Teas for the amelioration of the effects of alcoholic drinks and processes for the production thereof
DE69933539D1 (de) Pharmazeutische zusammensetzung enthaltend baicalin, chlorogensäure und forsythiaside in isolierter und gereinigter form und verfahren zur herstellung
EP1707238A4 (de) Pharmazeutika aus der traditionellen chinesischen medizin zur behandlung von lungenkrebs und herstellungsverfahren dafür
WO2009043176A9 (en) Herbal compositions and methods for treating hepatic disorders
Antul et al. Review on pharmacological profile of medicinal vine: Tinospora cordifolia
AU2003216884A1 (en) Plant extracts and the use thereof
Islam et al. Neuropharmacological screenings of hydroalcoholic fractions of Urena lobata L
Abdullahi et al. Analgesic and anti-inflammatory effects of aqueous leafextract of Combretum micranthumg. Don (Combretaceae)
EP1972337A3 (de) Arzneistoff und verbessertes Verfahren zur Herstellung eines extrahierten, verdampften, granulatförmigen botanischen Kräuterprodukts
Rahman et al. A new C-benzylated chalcone from Desmos chinensis
Sozer et al. Constituents from the leaves of Crataegus davisii Browicz
WO2003013564A3 (en) An herbal composition for the treatment and remedy of bronchial respiratory difficulties
Abagale et al. Chemical analyses of aqueous extract of Parkia biglobosa fruit husk collected from Northern Ghana
Ogukwe et al. Evaluation of the Antitumour Agents in Annona muricata (Linn.) Leaves Using Column Chromatography and Gas Chromatography-Mass Spectrometry
Otshudi et al. Antidiarrhoeal activity of root extracts from Roureopsis obliquifoliolata and Epinetrum villosum
Begum et al. In vivo evaluation of antidiarrhoeal activity of the leaves of Azima tetracantha Linn
Wangchuk Phytochemical analysis, bioassays and the identification of drug lead compounds from seven Bhutanese medicinal plants
AU7020000A (en) Herbal compositions for itchy or infected skin
Shafiee et al. Corydine and norcorydine from the roots of Chelidonium majus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001956248

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10333627

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001956248

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001956248

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP